Thermo Fisher Scientific (TMO) Change in Account Payables (2009 - 2020)

Thermo Fisher Scientific has reported Change in Account Payables for 12 years, with the latest figure at $279.0 million in Q4 2020.

• Change in Account Payables for Q4 2020 came in at $279.0 million, up 42.35% year-over-year; the trailing twelve-month figure through Dec 2020 was $59.0 million (down 77.82% YoY), and the FY2025 annual result was $421.0 million, up 98.58% from the prior year.
• Change in Account Payables advanced to $279.0 million in Q4 2020, from $277.0 million in the prior quarter.
• Over five years, Change in Account Payables peaked at $279.0 million in Q4 2020 and troughed at -$256.0 million in Q2 2020.
• A 5-year average of $42.8 million and a median of $15.6 million in 2016 frame the typical range for Change in Account Payables.
• The largest YoY upside for Change in Account Payables was 2812.87% in 2017 against a maximum downside of 1374.51% in 2017.
• A 5-year view of Change in Account Payables shows it stood at -$10.1 million in 2016, then soared by 2812.87% to $274.0 million in 2017, then fell by 10.22% to $246.0 million in 2018, then slipped by 20.33% to $196.0 million in 2019, then jumped by 42.35% to $279.0 million in 2020.
• Per Business Quant data, the three most recent Change in Account Payables figures were $279.0 million in Q4 2020, $277.0 million in Q3 2020, and -$256.0 million in Q2 2020.